These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 22280397)

  • 1. Evaluation of skin samples for bovine viral diarrhea virus by use of reverse transcriptase polymerase chain reaction assay after vaccination of cattle with a modified-live bovine viral diarrhea virus vaccine.
    Corbett EM; Grooms DL; Bolin SR
    Am J Vet Res; 2012 Feb; 73(2):319-24. PubMed ID: 22280397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
    J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficacy of a reverse transcriptase-polymerase chain reaction assay to screen cattle for persistent bovine viral diarrhea virus infection.
    Kennedy JA
    J Am Vet Med Assoc; 2006 Nov; 229(9):1472-4. PubMed ID: 17078812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of vaccination of seronegative bulls with modified-live, cytopathic bovine viral diarrhea viruses.
    Givens MD; Riddell KP; Zhang Y; Galik P; Walz PH; Brodersen BW; Johnson JW; Passler T; Widel P; Tremblay R
    Theriogenology; 2009 Apr; 71(6):975-83. PubMed ID: 19144395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
    Bolin SR; Lim A; Grotelueschen DM; McBeth WW; Cortese VS
    Am J Vet Res; 2009 Jan; 70(1):86-91. PubMed ID: 19119952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diagnostic tests used for detection of bovine viral diarrhea virus and prevalence of subtypes 1a, 1b, and 2a in persistently infected cattle entering a feedlot.
    Fulton RW; Hessman B; Johnson BJ; Ridpath JF; Saliki JT; Burge LJ; Sjeklocha D; Confer AW; Funk RA; Payton ME
    J Am Vet Med Assoc; 2006 Feb; 228(4):578-84. PubMed ID: 16478438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W; Mattick D; Smith L
    Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea.
    Cortese VS; Whittaker R; Ellis J; Ridpath JF; Bolin SR
    Am J Vet Res; 1998 Jul; 59(7):848-50. PubMed ID: 9659549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
    Kleiboeker SB; Lee SM; Jones CA; Estes DM
    J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
    Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
    Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of oral swab sample for the detection of bovine viral diarrhea virus (BVDV) gene from the cattle persistently infected with BVDV.
    Tajima M; Ohsaki T; Okazawa M; Yasutomi I
    Jpn J Vet Res; 2008 May; 56(1):3-8. PubMed ID: 18624254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncytopathic bovine viral diarrhea virus can persist in testicular tissue after vaccination of peri-pubertal bulls but prevents subsequent infection.
    Givens MD; Riddell KP; Walz PH; Rhoades J; Harland R; Zhang Y; Galik PK; Brodersen BW; Cochran AM; Brock KV; Carson RL; Stringfellow DA
    Vaccine; 2007 Jan; 25(5):867-76. PubMed ID: 17005300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental persistent infection with bovine viral diarrhea virus in white-tailed deer.
    Passler T; Walz PH; Ditchkoff SS; Givens MD; Maxwell HS; Brock KV
    Vet Microbiol; 2007 Jun; 122(3-4):350-6. PubMed ID: 17353103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.